On December 29, Alignment Healthcare insider Christopher Joyce completed a sale of 16,187 shares, representing a 5.00% reduction in his position. Following the transaction, Joyce directly holds 307,699 shares, valued at approximately $5.77 million. The disposal generated gross proceeds of $303,344.38, and the sale was disclosed in an SEC filing available for public inspection.

The Joyce sale formed part of a wider round of dispositions by senior executives on December 29–30. CEO John E. Kao divested 605,648 shares (21.3% of his stake) for proceeds of about $11.35 million, President Dawn Christine Maroney sold 282,070 shares for roughly $5.29 million, and other directors—including Robert L. Scavo and Hyong Kim—offloaded an additional 98,235 shares. Collectively, insiders disposed of nearly one million shares in this two-day period, signaling potential shifts in internal sentiment.

In its most recent quarter, Alignment Healthcare reported revenue of $993.7 million, a 43.5% increase year-over-year, and delivered EPS of $0.02, beating consensus by $0.03. The company’s debt-to-equity ratio stands at 1.99, with both quick and current ratios at 1.61. Institutional ownership accounts for 86.2% of shares outstanding. Wall Street sentiment remains constructive: one analyst rates the stock as a Strong Buy, eight as Buy, three as Hold and one as Sell, reflecting broad confidence in the company’s value-based care model and growth trajectory.